MarketCapTrends
GKOS

Glaukos Corporation (GKOS)

NYSE · Healthcare

Glaukos Corporation annual/quarterly shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Glaukos Corporation shareholder equity for the quarter ending December 31, 2025 were 656.2M, a 14.44% decrease year-over-year.
  • Glaukos Corporation shareholder equity for 2025 were 656.2M, a 14.44% decrease from 2024.
  • Glaukos Corporation shareholder equity for 2024 were 766.9M, a 66.09% increase from 2023.
  • Glaukos Corporation shareholder equity for 2023 were 461.8M, a 12.88% decrease from 2022.
  • Glaukos Corporation shareholder equity for 2022 were 530.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Glaukos Corporation Annual Shareholder Equity (Millions of US $)
2025$656
2024$767
2023$462
2022$530
2021$587
2020$667
2019$673
2018$174
2017$138
2016$117
2015$95
2014$-151
Glaukos Corporation Quarterly Shareholder Equity (Millions of US $)
2025-12-31$656
2024-12-31$767
2023-12-31$462
2022-12-31$530
2021-12-31$587
2020-12-31$667
2019-12-31$673
2018-12-31$174
2017-12-31$138
2016-12-31$117
2015-12-31$95
2014-12-31$-151

Glaukos Corporation Shareholder Equity — FAQ

Glaukos Corporation (GKOS) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see GKOS's shareholder equity history?

The chart and table above show Glaukos Corporation's shareholder equity by year and by quarter, including the growth rate.